SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Principal Pharmaceuticals to invest up to Rs 3 crore in Inovent Solutions

11 Dec 2012 Evaluate

Principal Pharmaceuticals & Chemicals has received an approval for investment of up to Rs 3 crore in Inovent Solutions subject to 60% of the company’s paid up capital and free reserves, towards expanding its digital and eCommerce activities. The board at its meeting held on December 10, 2012 has approved for the same.

Inovent Solutions offers end to end eCommerce Services to large number of brands either directly or through leading ecommerce platforms. The investment shall be made in single or multiple tranches and by way of equity shares in Inovent Solutions.

Principal Pharmaceuticals & Chemicals manufactures various products like 3,4,5 TMB Methyl Easter, ChloroPropiophenone etc, including the following ones as ‘specialty’ products.

iStreet Network Share Price

48.43 0.94 (1.98%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×